Filing Details
- Accession Number:
- 0001437749-24-003155
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2024-02-05 21:16:49
- Reporting Period:
- 2024-01-31
- Accepted Time:
- 2024-02-05 21:16:49
- Original Submission Date:
- 2024-02-02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1668243 | Urogen Pharma Ltd. | URGN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1821479 | Drew Jason Smith | 400 Alexander Park Drive Princeton NJ 08540 | General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2024-02-01 | 417 | $15.78 | 18,824 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2024-02-01 | 1,248 | $15.78 | 20,076 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2024-02-01 | 3,328 | $15.78 | 23,414 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- This amendment corrects and restates the date of sale reported in the original Form 4 filed on February 2, 2024.
- This amendment corrects and restates the sales price reported in the original Form 4 filed on February 2, 2024.